Unicorn Wrangling
Theranos Crackdown Offers Welcome Check on Tech Startup Frenzy
It's a timely reminder to investors that not all startups lead to riches.
This article is for subscribers only.
Theranos did no favors for its investors, but it may have unwittingly helped the next generation of innovators.
The Securities and Exchange Commission last week accused the company and its CEO, Elizabeth Holmes, of misleading investors. According to the SEC’s complaint, Theranos lied about the capabilities of its blood-testing technology on its way to raising $700 million from 2013 to 2015.